stop semaglutide Semaglutide: Half of Users Drug Within Year in 'Concerning' Drop Off Half of people stop taking
Description
These drugs mimic the physiological effects of GLP-1 by binding to GLP-1R, which enhances insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces food intake (Drucker, 2018)
Many of the patients who received vials of compounded semaglutide lacked experience with self-injections, according to the adverse event reports
But Novo Nordisk's treatment is much earlier in development, meaning it will take several years before it reaches patients.
I believe thats the primary motivation behind this, said Mark Boesen, an attorney and former compounding pharmacist
